Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vidailhet

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
L'Encephale|March 3, 2012
[RÉALITÉ LT, a pharmacoepidemiological study of semiology and therapeutic strategy of patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice]F-R Cousin, J-C Samuelian, M Saoud, et al.
Multiple Sclerosis and Related Disorders|April 12, 2016
Should a psychotic or manic episode be considered an early manifestation of Multiple Sclerosis? A multiple case studyF Berna, F Blanc, C Lebrun, et al.
L'Encephale|May 7, 2020
[Health professionals facing the coronavirus disease 2019 (COVID-19) pandemic: What are the mental health risks?]W El-Hage, C Hingray, C Lemogne, et al.
Journal of Affective Disorders|November 15, 2018
Inflammatory DEpression Advances in Schizophrenia (IDEAS): A precision medicine approach of the national FACE-SZ cohortG Fond, O Godin, F Schürhoff, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 25, 2019
Sexual dysfunctions are associated with major depression, chronic inflammation and anticholinergic consumption in the real-world schizophrenia FACE-SZ national cohortG Fond, O Godin, M Dumontaud, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 16, 2018
Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohortG Fond, E Bulzacka, M Boucekine, et al.
Schizophrenia Research|November 22, 2015
Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ datasetF Berna, D Misdrahi, L Boyer, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 27, 2017
Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohortG Fond, F Berna, M Andrianarisoa, et al.
Schizophrenia Research|January 23, 2017
Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohortM Andrianarisoa, L Boyer, O Godin, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 17, 2020
Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohortG Fond, O Godin, F Schürhoff, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
L'Encephale|March 3, 2012
[RÉALITÉ LT, a pharmacoepidemiological study of semiology and therapeutic strategy of patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice]F-R Cousin, J-C Samuelian, M Saoud, et al.
Multiple Sclerosis and Related Disorders|April 12, 2016
Should a psychotic or manic episode be considered an early manifestation of Multiple Sclerosis? A multiple case studyF Berna, F Blanc, C Lebrun, et al.
L'Encephale|May 7, 2020
[Health professionals facing the coronavirus disease 2019 (COVID-19) pandemic: What are the mental health risks?]W El-Hage, C Hingray, C Lemogne, et al.
Journal of Affective Disorders|November 15, 2018
Inflammatory DEpression Advances in Schizophrenia (IDEAS): A precision medicine approach of the national FACE-SZ cohortG Fond, O Godin, F Schürhoff, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 25, 2019
Sexual dysfunctions are associated with major depression, chronic inflammation and anticholinergic consumption in the real-world schizophrenia FACE-SZ national cohortG Fond, O Godin, M Dumontaud, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 16, 2018
Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohortG Fond, E Bulzacka, M Boucekine, et al.
Schizophrenia Research|November 22, 2015
Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ datasetF Berna, D Misdrahi, L Boyer, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 27, 2017
Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohortG Fond, F Berna, M Andrianarisoa, et al.
Schizophrenia Research|January 23, 2017
Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohortM Andrianarisoa, L Boyer, O Godin, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 17, 2020
Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohortG Fond, O Godin, F Schürhoff, et al.
Pageof 4